IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease BRENTWOOD, Tenn., Aug. 05, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative...

IMAC Regeneration Centers Continues Partnership with the U.S. Federal Government as a Provider of Health Care for the Department of Labor Office of Workers’ Compensation Programs IMAC Regeneration Centers Approved to Provide Medical Treatment, Physical Therapy and Chiropractic Care for the Division of Energy Employees Occupational Illness Compensation (DEEOIC), Federal...

IMAC Initiates Next Phase of Brand Ambassador Program With Opening of Mike Ditka Center in Arlington Heights, Ill. BRENTWOOD, Tenn, Oct. 09, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...

IMAC Holdings Second Quarter 2019 Financial Results Feature Continued Significant Revenue Increase BRENTWOOD, Tenn, Aug. 16, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of Innovative Medical Advancements and Care, specializing in regenerative...